Digital twin technology set to takeover cardiology devices industry in India: GlobalData

GlobalData’s research reveals that Indian cardiology market, which accounted for 23 per cent of the Asia-Pacific market in 2021, is expected to grow at a compound annual growth rate of 5 per cent through 2030

Digital (virtual) twin technology has been so progressing that it now allows for tailored and predictive health treatment in India. The technology develops a virtual prototype for a real-life product that can monitor, evaluate, and enhance its performance in the cardiology market by bridging the real and virtual world, and it will not be long until digital twin technology takes over the existing cardiology devices industry in India, says GlobalData.

GlobalData’s research reveals that Indian cardiology market, which accounted for 23 per cent of the Asia-Pacific market in 2021, is expected to grow at a compound annual growth rate of 5 per cent through 2030.

Ayshi Ganguly, Medical Devices Associate Analyst, GlobalData comments, “By combining the virtual and real worlds, several startups are expected to leverage the twin technology in India by creating digital twins of organs and modify the medical devices using 3D printing. Twin-tech is expected to not only improve the shelf-life and performance of the cardiological devices, but also reduce animal testing over time, thereby helping to speed up the design of medical equipment.”

Modeling, labor, machineries, materials, methods, and measurement may all be validated digitally, thereby decreasing waste, and increasing energy efficiency. Cardiological sectors are expected to use this method to integrate sustainability into the heart of their operations, bringing strategy, design, and manufacturing together under one roof.

Twin technology has not only stepped into life sciences but has also taken into consideration human body modelling. Indian startups plan to build a platform for cardiovascular research by customizing affordable devices like implants and stents for heart patients in India.

The startups also want to incorporate 3D printing into an automated process for creating patient-specific implants and single-use surgical equipment. This will ensure the quality check of each patient, thereby boosting treatment quality.

Ganguly concludes, “Digital twin technology is expected to aid medical startups in India to better understand customers’ demands, develop changes to existing products, operations, and services, and even drive innovation and revenue.”